Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8091469 | 0.88 | ADRA1D (0.33) | ADRA1DADRA1AHPGDL3MBTL1KDM4E | |
| SCHEMBL8090137 | 0.84 | NPC1 (0.45) | HPGDL3MBTL1RAB9AKMT2A | |
| SCHEMBL8090106 | 0.84 | ITGB3 (0.37) | ADRA1DADRA1AKMT2A | |
| SCHEMBL8090129 | 0.77 | ALDH1A1 (0.34) | RAB9A | |
| SCHEMBL8091473 | 0.76 | — | — | |
| SCHEMBL8083536 | 0.75 | F2 (0.39) | RAB9A | |
| SCHEMBL8083538 | 0.75 | F2 (0.39) | RAB9A | |
| SCHEMBL8091412 | 0.75 | ALDH1A1 (0.34) | — | |
| SCHEMBL9248972 | 0.74 | CA2 (0.42) | HPGDKDM4ELMNA | |
| SCHEMBL8095297 | 0.74 | F2 (0.40) | RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0792883-B1 | Novel derivates of boronic acid, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 2000-12-20 | — | — | EP | disclosed |
| EP-0792883-A1 | Novel derivates of boronic acid, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1997-09-03 | — | — | EP | disclosed |